Carnitine: a false dawn in the treatment of muscle weakness in end-stage renal failure patients?
作者信息
Davenport Andrew
机构信息
Department of Nephrology and Transplantation, Royal Free Hospital, London, UK.
出版信息
Nephron Clin Pract. 2004;97(2):c33-4. doi: 10.1159/000078397.
PMID:15218327
Abstract
摘要
相似文献
1
Carnitine: a false dawn in the treatment of muscle weakness in end-stage renal failure patients?
Nephron Clin Pract. 2004;97(2):c33-4. doi: 10.1159/000078397.
2
Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
Nephron Clin Pract. 2004;97(2):c41-8. doi: 10.1159/000078399.
3
The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
Clin Nephrol. 1997 Jun;47(6):372-8.
4
Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
Am J Kidney Dis. 1998 Aug;32(2):258-64. doi: 10.1053/ajkd.1998.v32.pm9708610.
5
Newer aspects of carnitine metabolism in uremia.
Semin Nephrol. 2006 Jan;26(1):52-5. doi: 10.1016/j.semnephrol.2005.06.010.
6
Carnitine replacement in end-stage renal disease and hemodialysis.
Ann N Y Acad Sci. 2004 Nov;1033:52-66. doi: 10.1196/annals.1320.005.
7
[Carnitine metabolism in chronic kidney failure].
Clin Ter. 1992 Jan;140(1 Pt 2):31-4.
8
Exercise rehabilitation and skeletal muscle benefits in hemodialysis patients.
Clin Nephrol. 2004 May;61 Suppl 1:S46-50.
9
L-carnitine in dialysed patients: the choice of dosage regimen.
Int J Clin Pharmacol Res. 1995;15(3):127-33.
10
Dialysis-related carnitine disorder.
Semin Dial. 2006 Jul-Aug;19(4):323-8. doi: 10.1111/j.1525-139X.2006.00180.x.
Zotero 插件